GASTROESOPHAGEAL REFLUX DISEASE
DEFINITION:
The return of an abnormal quantity of gastric contents into the
esophagus resulting in gastrointestinal, respiratory, and/or
neurobehavioural manifestations.
EPIDEMIOLOGY:
- incidence: ?
- age of onset:
- provocative factors:
- supine positioning
- smoking
- certain foods and medications (see Management)
PATHOGENESIS:
- all infants and children reflux occasionally
- brief episodes of postprandial reflux is normal
- must differentiate physiologic from pathogenic reflux
2. Pathogenic Regurgitant Reflux
- differs from physiologic reflux in two ways:
1. Quantity
- abnormal quantity of reflux
- increased frequency and/or duration of episodes
2. Detrimental Effects
- Gastrointestinal
- Respiratory
- Neurobehavioural
2. Pathogenesis
- a disturbance of the normal functioning of the esophagus and
related structures results in defective antireflux barrier
- 1. Gastric Dysfunction
- increased volume of gastric contents
- increased abdominal pressure (obesity, tight clothes)
- 2. Lower Esophageal Sphincter (LES) Dysfunction
- transient relaxation of LES (major cause of reflux)
- basal relaxation of LES (minor cause of reflux)
- 3. Esophageal Dysfunction
- impaired esophageal clearance of refluxate
CLINICAL FEATURES:
1. Infants
1. Gastrointestinal Manifestations
- failure to thrive
- malnutrition
- esophagitis
- feeding problems
- irritability
- hematemesis
- anemia
2. Respiratory Manifestations
- apnea (obstructive)
- chronic cough
- wheeze
- pneumonia (chronic or recurrent)
- cyanotic spells
- others - stridor, hiccups, hoarseness
- reflux with respiratory complications are more likely to
be observed in association with certain disorders in both
infants and children, i.e., esophageal atresia, Cystic
Fibrosis, Bronchopulmonary Dysplasia, Tracheoesophageal
- Fistula
3. Neurobehavioural Manifestations
- arching and stiffening
- hyperextenstion of the neck or markedly flexed to one side
(torticollis of Sandifer Syndrome)
2. Children/Adolescence
1. Gastrointestinal Manifestations (Esophagitis)
- chest pain (heartburn [pyrosis])
- dysphagia (difficult swallowing)
- hallitosis (refluxate in mouth)
- odynophagia (painful swallowing)
- waterbrush (flow of salty saliva into mouth)
- hematemesis
- anemia (iron-deficient)
2. Respiratory Manifestations
- recurrent or chronic pneumonias
- recurrent wheeze
- chronic cough
- others - stridor, hoarseness
INVESTIGATIONS:
1. pH Monitering
- placement of a pH probe into the distal esophagus to moniter
the total time that there is acid (pH <4) in the distal
esophagus
- considered the "gold standard" for the diagnosis of
pathogenic reflux
- quantifies the frequency and duration of acid reflux for
prolonged periods
- detects a temporal relationship between episodes of reflux
and discrete signs and symptoms (neurobehavioural
manifestations)
- identifies "at risk" conditions, i.e., sleeping, coughing
- limitations:
- cannot detect nonacid reflux
- 24 hours in duration
- limited availability
2. Scintigraphic Monitering
- adding of radiolabelled (technetium 99m sulfer colloid) to
feed
- detects postprandial reflux and gastric emptying
3. Barium Esophagram/Upper GI Fluoroscopy
- performed following a barium meal
- provides a crude quantification of the frequency and
duration of reflux
- less sensitive for aspiration reflux
- rules out structural and functional anomalies fo the upper
GI tract, i.e., strictures, hiatal hernias, pyloric stenosis,
etc.
4. Endoscopy +/- Esophageal Biopsy
- detects esophagitis (erosions, ulcerations), strictures,
gastric peptic disease
5. Esophageal Manometry
- detects specific motility anomalies and low LES pressure
- does not detect reflux
6. Chest X-Ray
- aspiration and/or recurrent pneumonias
MANAGEMENT:
I. APPROACH
1. Diagnosis
2. Education
3. Goals of Therapy
4. Treatment Options
5. Management Strategies
1. Conservative
2. Pharmacologic
1. Prokinetic
2. Acid-Reducing
3. Barrier
3. Surgical
1. Diagnosis
- based on history, physical, and investigations
2. Education
- discuss diagnosis with parents and explain physiologic from
pathogenic reflux
3. Goals of Therapy
- to eliminate the detrimental effects of reflux -
gastrointestinal, respiratory, and/or neurobehavioural
manifestations
4. Treatment Options
1. No Therapy
- 60-65% of infants with severe reflux will be asymptomatic
without therapy by 2 years of age
2. Therapy
5. Management Strategies
1. Conservative
1. Position
- place in prone or upright positions
- avoid supine or semiseated position
- head of bed elevation may be useful
2. Feeding
- thicken infant feedings (1 tablespoon of dry rice
cereal/oz. formula)
- fast before sleeping
- avoid large meals (smaller but more frequent feeds)
- diet if overweight or obese
- avoid foods that decrease the LES pressure or increase
gastric acidity
- alcohol - coffee
- carbonated drinks - fatty foods
- citrus fruits - tomatoes
3. Avoidance
- avoid tight fitting clothes
- avoid tobacco smoke
- avoid medications that decrease the LES pressure or
increase gastric acidity
- adrenergics
- anticholinergics
- calcium-channel blockers
- prostaglandins
- xanthines (caffeine, theophylline)
2. Pharmacologic
1. Prokinetic Agents
- mechanism of action: act to raise the basal LES
pressure, improve esophageal clearance, increase rate of
gastric emptying
- trial of 8 weeks
- 1. Cisapride
- 0.3 mg/kg/dose po tid to be given before meals
- noncholinergic, nonantidopaminergic agent that
increases postganglionic acetylcholine release
- 2. Others
- Cholinergic Agonists (Bethanechol)
- Dopamine Antagonists (Domperidone)
- may be used as a first line therapy
- 5 mg po qid (before feeds)
2. Acid-Reducing Agents
- tend to use in older patients with pain associated with
esophagitis
- 1. Histamine Antagonists
- 1. Cimetidine (Tagamet)
- 2. Ranitidine (Zantac)
- 2. Antacids
- 0.5-1.0 mm3/kg/dose po 3-8x/day
3. Barrier Agents
1. Sulcralfate
- mechanism of action: coats damaged mucosa, inhibits
pepsin activity, adsorbs bile salts
- 1 gm in 5-15cc solution po qid
- used rarely in children
3. Surgery
1. Indications
- failure of medical management
- severe or intractable detrimental effects, i.e.,
failure to thrive, recurrent pneumonias
- peptic strictures
- neurologically-impaired children +/- G-tube
2. Nissen Fundoplication +/- G-Tube Insertion
- surgery acts to increase LES pressure
- 90% success rate
- complications:
1. Short Term
- herniation of wrap through the hiatus
- small bowel obstruction due to adhesions
- intraperitoneal leakage
2. Long Term
- inability to burp (gas bloat)
- inability to vomit when necessary
- dysphagia
- loosening of wrap
6. Prognosis
1. Infants
1. Mild/Moderate Reflux
- majority symptom-free and able to discontinue medical
therapy by 1 year of age
2. Severe Reflux
- 60-65% asymptomatic without therapy by 2 years of age
2. Children
- more resistant to complete resolution with good response
to medical therapy but relapse when discontinued
INTERNET LINKS:
Pediatric/Adolescent Gastroesophageal Reflux Association (PAGER)
CSMC NICU Teaching Files: GER
Gastroesophageal Reflux in Infants
|